Arcutis’s Zoryve Succeeds In Second Phase III In Atopic Dermatitis

 
• By Joseph Haas
Atopic dermatitis
Arcutis moves toward adding AD to the Zoryve label • Source: Shutterstock

More from Clinical Trials

More from R&D